ALG-1001

· Allegro Ophthalmics, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ALG-1001, covering 2012-12-07 to 2018-07-18. Get the full timeline:

Most recent: Clinical Trial Update: A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion [Phase 2]